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ORIGINAL ARTICLE
Intimate Partner Violence and HIV Among Drug-Involved Women:
Contexts Linking These Two Epidemics—Challenges and Implications
for Prevention and Treatment
Nabila El-Bassel, Louisa Gilbert, Susan Witte, Elwin Wu and Mingway Chang
Social Intervention Group, School of Social Work, Columbia University, New York, New York, USA
Intimate partner violence (IPV) and HIV are two se-
rious overlapping public health epidemics that dispro-
portionately affect drug-involved women. This article
reviews research that has identified a number of con-
texts that may explain the links between IPV and HIV
transmission risks. These contexts include sexual coer-
cion, fear of violence, negotiation of condom use, ex-
tradyadic relationships, disclosure of sexually trans-
mitted infections or HIV seropositivity to intimate
partners, drug involvement of women and their male
partners, low social status of drug-involved women, re-
lationship dependencies, and sex ratio imbalances. The
article focuses on how the bidirectional relationship be-
tween IPV andHIV risks may be mediated by a history
of childhood sexual abuse and post-traumatic stress
disorder. Also addressed are the challenges that sub-
stance user treatment programs face in dealing with fe-
male clients who experience IPV and the implications
for HIV prevention.
Keywords HIV, partner violence, drug-involved women, risk
factors
INTRODUCTION
Intimate partner violence (IPV) has been identified as a
significant public health problem reaching epidemic pro-
portions in the United States and affecting women from
all walks of life, especially those who are drug-involved
(Amaro, 1995; Amaro, Fried, Cabral, & Zuckerman,
1990; Cunningham, Stiffman, Dore, & Earls, 1994;
El-Bassel, Gilbert, & Rajah, 2003; El-Bassel, Gilbert,
1Treatment can be briefly and usefully defined as a planned, goal-directed, temporally structured change process, of necessary quality,
appropriateness and conditions (endogenous and exogenous), which is bounded (by culture, place, time, etc.) and can be categorized into
professional-based, tradition-based, mutual-help-based (such as Alcoholics Anonymous and Narcotics Anonymous), and self-help (“natural
recovery”) models. There are no unique models or techniques used with substance users—of whatever types and heterogeneities—that are not also
used with nonsubstance users. In the West, with the relatively new ideology of “harm reduction” and the even newer quality-of-life treatment-driven
model, there are now a new set of goals in addition to those derived from/associated with the older tradition of abstinence-driven models. Treatment
is implemented in a range of environments—such as ambulatory and within-institution—that can include controlled environments. Editor’s note.
Address correspondence to Nabila El-Bassel, Social Intervention Group, Columbia University School of Social Work, 1255 Amsterdam Avenue,
New York, NY 10027; E-mail: ne5@columbia.edu
Rajah, Foleno, & Frye, 2000; Fernandez, 1995;
Fontdevila, El-Bassel, & Gilbert, 2005; Gilbert, El-
Bassel, Schilling, Wada, & Bennet, 2000; Wingood &
DiClemente, 1997; Worth, 1989; Wyatt, 1991). Studies
among women in substance user treatment1 have shown
that past-year prevalence rates of physical and sexual
IPV have ranged between 25% and 57% (El-Bassel et al.,
2003; El-Bassel, Gilbert, Rajah, Foleno, & Frye, 2001; El-
Bassel, Gilbert, Wu, Go, & Hill, 2005a; Fontdevila et al.,
2005; Gilbert, El-Bassel, Schilling, et al., 2000), which are
three to five times higher than the rate range of 8%–16%
found in epidemiological surveys of community-based
samples of women (Caetano, Nelson, & Cunradi, 2001;
Straus & Gelles, 1990; Tjaden & Thoennes, 1998).
In several studies conducted in New York City by
the authors of this article, prevalence rates of IPV were
found to be high among drug-involved women as well as
among a random sample of men in methadone treatment
who were asked to report about perpetrating IPV against
their female partners (El-Bassel, Gilbert, Wu, Chang, &
Fontdevila, 2007; El-Bassel et al., 2005a). In a recent
study among a random sample of 416 sexually active
women recruited from 11 methadone treatment programs
in New York City, we found that 88% of the women re-
ported physical and sexual IPV in their lifetime. Almost
three quarters of the women in this sample (73%) indi-
cated that they experienced severe physical or sexual IPV.
About one half (47%) reported experiencing physical or
sexual IPV in the past 6 months, and about one fifth (19%)
indicated that the physical or sexual IPV that they expe-
rienced in the past 6 months was severe (El-Bassel et al.,
2005a).
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In a study among a random sample of 356 men re-
cruited from sevenmethadone treatment programs in New
York City, we found that 58% of the men reported ever
perpetrating physical and/or sexual IPV, and 38% admit-
ted to perpetrating physical and/or sexual IPV in the past
6 months (El-Bassel et al., 2007). Among this sample,
32% reported ever sexually coercing their female partners
(forced sex without using physical force), and 21% had
sexually coerced their partners in the past 6 months; 16%
reported ever physically forcing their partners to have sex
against their will (rape), and 7% reported physically forc-
ing their partner to have sex in the past 6 months. Perpe-
tration rates of IPV in this study were higher among men
who reported that their female partners were using drugs
compared with those with non-drug-using female partners
(El-Bassel et al., 2007).
High rates of IPV may be playing a major role in fu-
eling the heterosexual transmission of HIV, as condoms
are less likely to be used by partners in long-term rela-
tionships where IPV is present. In 2006, women com-
posed 26% of all HIV/AIDS cases in the United States,
and of these, 73%were infected through heterosexual con-
tact (Centers for Disease Control and Prevention, 2006).
In this same year, females made up 27% of newHIV cases
in NewYork City, and of these women, 63%were infected
through heterosexual intercourse (New York City Depart-
ment of Health and Mental Hygiene, 2007).
Research suggests that the relationships between expe-
riencing IPV and different HIV transmission risks among
heterosexual women are multifaceted and complex.
Accumulating research conducted with heterosexual
women has found that experiencing IPV is associated
with (1) engaging in unprotected sex (Bassuk et al.,
1997; Cunningham et al., 1994; El-Bassel et al., 2005a;
Fernandez, 1995; Gielen, McDonnell, & Ocampo, 2002;
Gilbert, El-Bassel, Rajah, et al., 2000; Hamburger et al.,
2004; Raj, Silverman, & Amaro, 2004; Saul, Moore,
Murphy, & Miller, 2004; Tucker, Wenzel, Elliott,
Marshall, & Williamson, 2004; Wingood & DiClemente,
1997; Wyatt, 1991), (2) higher rates of sexually trans-
mitted infections (STIs; El-Bassel, Gilbert, Schilling, &
Wada, 2000; Hogben et al., 2001; Rodriguez, Szkupinski
Quiroga, & Bauer, 1996; Wu, El-Bassel, Witte, Gilbert,
& Chang, 2003), (3) having sex with multiple partners
(Gilbert, El-Bassel, Rajah, et al., 2000; Rich et al., 1999;
Wu et al., 2003), (4) trading sex for money or drugs
(Beadnell, Baker, Morrison, & Knox, 2000; El-Bassel,
Gilbert, Schilling, et al., 2000), (5) having sex with in-
jecting drug users (Gilbert, El-Bassel, Rajah, et al., 2000;
Rich et al., 1999), and (6) having sex with HIV-positive
partners (El-Bassel et al., 2005a).
Emerging research has also found associations between
perpetration of IPV and engaging in HIV risk behaviors
among heterosexual men (El-Bassel, Fontdevila, et al.,
2001; Gilbert, El-Bassel, Wu, & Chang, 2007; Raj et al.,
2006). A cross-sectional study with a nonrandom sam-
ple of 283 sexually active young adult men recruited from
an urban community health center found that participants
who reported perpetrating IPV during the past year were
significantly more likely to report (1) inconsistent or no
condom use, (2) forced vaginal sex without a condom, and
(3) sex with multiple female partners (Raj et al., 2006). A
cross-sectional study with 273 men in methadone treat-
ment programs found that men who reported perpetration
of IPV were more likely to have had more than one inti-
mate partner and more likely to have had sex with a drug-
injecting sexual partner than their counterparts (El-Bassel,
Fontdevila, et al., 2001).
Our recent longitudinal research with women and men
in methadone treatment further suggests that these mul-
tifaceted relationships between IPV and HIV risks are
bidirectional (El-Bassel, Gilbert, Wu, Go, & Hill, 2005b;
Gilbert et al., 2007). In our longitudinal study of a random
sample of 416 women in methadone treatment in New
York City who received repeated assessments at baseline
(wave 1), 6 months (wave 2), and 12 months (wave 3), we
found that women who always reported using condoms at
wave 2 were significantly less likely to report experienc-
ing IPV at wave 3 than women who reported no or incon-
sistent condom use at wave 2 after controlling for poten-
tially confounding sociodemographic variables assessed
at wave 1 (El-Bassel et al., 2005b). Similarly, increased
risk of IPV at wave 3 was associated with self-reported
STIs at wave 2. Study findings also suggested that experi-
encing IPV at wave 2 decreased the likelihood of always
using condoms and requesting partners to use condoms
at wave 3 (El-Bassel et al., 2005b). In our longitudinal
study of a random sample of 356 men on methadone, we
found (1) that perpetration of IPV in the past 6 months
at wave 1 was associated with having more than one inti-
mate partner and buying sex at subsequent waves and (2)
that no condom use, injecting drugs, and sexual coercion
at wave 1 were associated with subsequent IPV (Gilbert
et al., 2007).
In this article, we discuss a number of overlapping
contexts found in the literature to explain the bidirec-
tional, multifaceted links between IPV and HIV risks
among drug-involved women. These contexts include
sexual coercion, fear of violence, negotiation of con-
dom use, extradyadic relationships, disclosure of HIV
seropositivity or STIs to intimate partners, drug involve-
ment of women and their male partners, relationship
dependencies, and sex ratio imbalances. These contexts
overlap, but for the purpose of this article, we present
each context separately, using research from the United
States, primarily from our studies conducted in New
York City. The article also discusses the challenges that
substance user treatment programs face in dealing with
female clients who experience IPV and the need for
integrated HIV prevention approaches that consider the
contexts that link IPV and HIV risks.
MECHANISMS LINKING IPV AND HIV RISKS
AMONG DRUG-INVOLVED WOMEN
Sexual Coercion
Growing research suggests that sexual coercion is one of
the major contexts associated with HIV transmission risks
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(Beadnell et al., 2000; Maman, Campbell, Sweat, & Gie-
len, 2000; Wingood & DiClemente, 1998), especially for
drug-involved women (Frye, El-Bassel, Gilbert, Rajah, &
Christie, 2001). In several of our studies with women in
methadone treatment, we found that women who reported
experiencing sexual IPV were more likely to report never
using condoms, compared with women who did not re-
port such IPV (El-Bassel, Gilbert, Schilling, et al., 2000;
El-Bassel et al., 2005a; Gilbert, El-Bassel, Schilling, et
al., 2000). This finding is consistent with other studies
that have found an association between sexual coercion
and lack of condom use (Beadnell et al., 2000; Frye et al.,
2001; Go et al., 2003; Maman et al., 2000; Wingood &
DiClemente, 1998).
Data from in-depth interviews that we conducted with
38 women in methadone treatment in New York City
showed that most reported that they consistently forgo
requesting condoms when they are pressured into hav-
ing sex by an intimate partner, fearing that such re-
quests may further provoke their partner and jeopardize
their safety (El-Bassel, Gilbert, Schilling, et al., 2000).
The goal of women in these forced encounters is to
avoid physical harm and to ensure that the experience is
over as quickly as possible (El-Bassel, Gilbert, Schilling,
et al., 2000; El-Bassel et al., 2005a). Sexual coercion cre-
ates a context of male dominance and control that strips
women of the power to negotiate their sexual health needs
(El-Bassel, Gilbert, Schilling, et al., 2000). In another
qualitative study conducted with 62 men on methadone
in New York City who perpetrated IPV against their fe-
male partners, the majority reported that women are not
to be believed when they refuse sex (Fontdevila et al.,
2005). The men reported that women really want to have
sex; therefore, forcing sex is perceived as a normative
reaction among most of these men (Fontdevila et al.,
2005).
Research has also linked sexual coercion to risks of
HIV and other STIs, in that sexual coercion and rape in-
creases the likelihood of vaginal lacerations and abrasions
when force is used (Jenny et al., 1990). Vaginal, anal,
and urethral trauma from forced sex can lead to increased
transmission of microorganisms through direct transmis-
sion into the bloodstream or backflow into the urethra
(Jenny et al., 1990).
Fear of IPV and HIV Risk
Fear of partner violence has been implicated as a risk fac-
tor for having unprotected sex in several qualitative and
quantitative studies (El-Bassel, Gilbert, Schilling, et al.,
2000; Gilbert, El-Bassel, Schilling, et al., 2000; Morrill
& Ickovics, 1996; Wingood & DiClemente, 1997). In in-
depth interviews with women on methadone, the majority
indicated that after experiencing IPV, some women may
be hesitant to attempt to negotiate condom use as well
as afraid to refuse unprotected sex (El-Bassel, Gilbert,
Schilling, et al., 2000; Gilbert, El-Bassel, Schilling,
et al., 2000). A cross-sectional study of 125AfricanAmer-
ican women in low-income housing found that women
who experienced sexual IPV were more likely than their
nonabused counterparts to report being afraid of asking
their partners to wear condoms because of the potential
violent reaction it may provoke (Kalichman, Williams,
Cherry, Belcher, & Nachimson, 1998). This context of
fear of violence renders women unable to shield them-
selves from HIV and other STIs. The failure to use con-
doms in relationships where the threat of IPV is present
may also explain the link between IPV and STIs found in
several studies (El-Bassel, Gilbert, Schilling, et al., 2000;
Gilbert, El-Bassel, Schilling, et al., 2000; Hogben et al.,
2001; Rodriguez et al., 1996; Wu et al., 2003).
Negotiating Condom Use and IPV
Consistent with other research among women in
methadone treatment (El-Bassel et al., 2005a, 2005b),
we found that requesting or insisting that a partner
use condoms was associated with experiencing IPV
(Gilbert, El-Bassel, Schilling, et al., 2000). Women who
always use condoms in their intimate relationships may
not need to negotiate with their partners because the
norm has already been established. In contrast, women
who sometimes use condoms and attempt to initiate or
renegotiate their use may increase their risk of IPV. Their
partners may perceive their inconsistent or new requests
to use condoms as a breach of gender role expectations
and a threat to the male’s sexual decision-making power
(El-Bassel et al., 2005a).
Furthermore, if a woman suspects that her partner is
having extradyadic affairs, injecting drugs, or engaging
in other risky behaviors, requesting that he use condoms
or get tested for HIV may signal to him a lack of trust
or caring (El-Bassel, Gilbert, Rajah, et al., 2000; Gilbert,
El-Bassel, Schilling, et al., 2000; Kelly & Kalichman,
1995; Kelly et al., 1993; Melendez, Hoffman, Exner,
Leu, & Ehrhardt, 2003). For some men, it may even
imply that she has engaged in risky behaviors and may be
perceived as a sign of infidelity on her part and a breach
of gender role expectations (El-Bassel, Gilbert, Rajah, et
al., 2000; Fontdevila et al., 2005). Such perceptions may
trigger jealousy and threaten the stability of the couple,
increasing the likelihood of abuse (O’Leary & Wingood,
2000), as some men resort to using physical and/or
sexual IPV as a mechanism to repair their masculine
self-esteem and maintain male power. In our qualitative
study with 62 men on methadone who perpetrated IPV
against their female partners, all agreed that requesting
condoms in a committed relationship creates mistrust
and conflict between partners that may ignite physical
and sexual abuse. In in-depth interviews with 38 women
in methadone treatment, several women indicated that
they had tried to protect themselves from HIV and other
STIs by refusing sex or at least refusing unprotected sex
(El-Bassel, Gilbert, Schilling, et al., 2000). To strike back
against these refusals, some women reported that their
partners would counteract with violence or threats of vio-
lence (El-Bassel, Gilbert, et al., 1998; El-Bassel, Gilbert,
Rajah, et al., 2000; Gilbert, El-Bassel, Schilling, et al.,
2000).
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Engaging in Extradyadic Affairs to Escape Relationship
Conflict and IPV
The relationship instability associated with IPV may in-
crease the likelihood that both partners will engage in ex-
tradyadic relationships as an exit strategy. Such affairs
may also be pursued by a male partner as a strategy of
retaliation, often with the explicit purpose of creating jeal-
ousy and a desire in a female partner to compete for recon-
nection (Gilbert et al., 2007). In such cases where women
fear losing their partners, it is unlikely that they will insist
on using condoms, even when they know that their part-
ners are sexually active with other women (Beadnell et al.,
2000). Although research has yet to document the precise
temporal sequences of shifting between intimate and ex-
tradyadic partners, lack of protection in these concurrent
relationships has the potential to increase the likelihood of
transmission of HIV and other STIs.
Disclosure of HIV/STIs and IPV
Findings on the relationship between disclosure of STIs
and HIV seropositivity and IPV have been somewhat
mixed. In a study with 50 HIV-positive women, the
women experienced positive (acceptance, understanding)
as well as negative consequences (rejection, abandon-
ment, physical abuse) following disclosure of their HIV
status (Gielen, O’Campo, Faden, & Eke, 1997). In our
longitudinal study with a random sample of 416 women
in methadone treatment, being HIV positive increased the
risk of subsequent IPV at 12-month follow-up (El-Bassel
et al., 2005b), which is consistent with previous research
that found an association between disclosure of an STI
or HIV positivity and subsequent IPV (Gielen, O’Campo,
Anderson, Keller, & Faden, 2000; Gielen et al., 1997;
North & Rothenberg, 1993; Rothenberg & Paskey, 1995).
Furthermore, qualitative research suggests that abused
women who tested positive for HIV or other STIs reported
that they were fearful of disclosing their status, knowing
that it may incite IPV (El-Bassel, Gilbert, Rajah, et al.,
2000).
RELATIONSHIP DEPENDENCIES
Research with drug-involved women has identified
three overlapping relationship dependencies on intimate
partners—housing and financial, drug, and social—that
increase risks for both IPV and HIV.
Housing and Financial Dependency
In our longitudinal study, we found that women who were
dependent on their partner for their housing were three
times more likely not to ask him to use condoms than
their counterparts (El-Bassel et al., 2005b). Women who
reported that they depend on their partners for household
expenses are twice as likely to report IPV as women who
did not report that their partner pays their household ex-
penses. These findings were also supported from our in-
depth interviews conducted with women on methadone
who indicated that when they need money, they acquiesce
to their partners’ demands, and their partners control when
and how they have sex (El-Bassel, Gilbert, Rajah, et al.,
2000).
Dependent on Partner for Drug Supply
In the longitudinal study, methadone-treated women who
reported that their partners supplied their illicit drugs were
twice as likely never to ask their partner to use condoms
as women whose partners did not supply their drugs (El-
Bassel et al., 2005b). In our focus groups and in-depth
interviews we learned that while most methadone-treated
women relied on their partners to supply them with drugs,
others said that they pay for and procure drugs for themale
partners, especially when the partner is going through
withdrawal (Gilbert, El-Bassel, Rajah, et al., 2000). De-
pending on the male partner to support their drug habit
makes women more likely to acquiesce to unprotected sex
and other risky behaviors. In addition, substance abuse2
may lead women to exchange sex for money or drugs in
risky unprotected encounters (El-Bassel, Gilbert, Rajah,
et al., 2000; Sterk, 1999). These women may also feel
pressured to sell sex to supply their addicted partners with
drugs (El-Bassel, Gilbert, Rajah, et al., 2000; Sterk, 1999).
Social Dependency
Social isolation that stems from the controlling behav-
iors of the male intimate sexual partner is common among
drug-involved women (Gilbert, El-Bassel, Rajah, Foleno,
& Frye, 2001). Drug-involved women have fewer friends,
especially female friends (El-Bassel, Gilbert, et al., 2001).
In a study of the social network profiles of women in
methadone treatment, more than two thirds were isolated
and had few non-drug-involved network members who
they could turn to for any type of support (El-Bassel,
Cooper, & Chen, 1998). In a random sample of 416
women on methadone, we found that 39% indicated that
their partner prevented them from going out; 14% were
prevented from getting drug treatment; and 13% said
that their partners kept them “as prisoners” (El-Bassel
et al., 2005a). Such controlling behaviors may undermine
women’s ability to negotiate condom use and safer rela-
tionships with their partners.
SEX RATIO IMBALANCE AND PERCEIVED SHORTAGE
OF ELIGIBLE MALE PARTNERS
The cultural value and social status placed on having a
male partner often keeps women from leaving abusive re-
lationships that put them at risk for HIV transmission. In
the in-depth interviews with women on methadone, they
frequently emphasized the social value that their friends
and people around them placed on the notion of having an
intimate partner (El-Bassel, Gilbert, Rajah, et al., 2000);
this was especially true of African American women.
Research has suggested that the sex ratio imbalance in
the African American community, where the number of
2The journal’s style utilizes the category substance abuse as a diagnos-
tic category. Substances are used or misused; living organisms are and
can be abused. Editor’s note.
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females substantially outpaces the number of males, ex-
acerbates power imbalances within intimate relationships,
rendering African American women with less power to
negotiate safe relationships (Mize, Robinson, Bockting,
& Scheltema, 2002). Moreover, in a social context where
the number of “available” African American men may be
limited because of incarceration and a higher death rate,
women may alter their self-protective behaviors in ways
that are driven by a fear of losing the present partner and
not being able to find another. For instance, a study of
low-income African American women found that fear of a
negative partner reaction—and, presumably, fear of losing
the partner as a result—was associated with lower levels
of condom use (Amaro & Raj, 2000). El-Bassel and col-
leagues (2000) suggest that the fear of disrupting a part-
nership when an alternative partner may not be available
plays an important role in determining whether or not a
woman is willing to insist on condom use. Moreover, the
fear of losing a partner not onlymay inhibit AfricanAmer-
ican women from requesting or insisting on condoms but
may also prevent them from resisting IPV or refusing drug
use within an intimate partnership (Mize et al., 2002).
THE ROLE OF DRUG AND ALCOHOL USE IN
FUELING IPV AND HIV RISK
Women’s Drug Use as a Mediator of IPV and HIV Risk
Drug and/or alcohol dependency by either or both
partners in a couple may mediate the multifaceted rela-
tionships between experiencing IPV and engaging in HIV
risks. Numerous studies have linked drug and alcohol use
with having unprotected sex, sex with a risky partner, sex
with multiple partners, and exchanging sex for money
or drugs, as well as with risks of HIV and other STIs
(Chiasson et al., 1990; Edlin et al., 1992, 1994). Accu-
mulating research has also found significant associations
between experiencing IPV and using different drugs
among women (Brewer, Fleming, Haggerty, & Catalano,
1998; Cottler, Compton, Mager, Spitznagel, & Janca,
1992; El-Bassel, Gilbert, Rajah, et al., 2000), including
alcohol use (Cunradi, Caetano, & Shafer, 2002; Field &
Caetano, 2003; Mcnutt, Carlson, Persaud, & Postmus,
2002), cocaine and marijuana use (Chermack, Fuller, &
Blow, 2000; El-Bassel, Gilbert, Rajah, et al., 2000; El-
Bassel et al., 2005b), heroin use (El-Bassel, Gilbert,Witte,
et al., 2003; El-Bassel et al., 2005b), and tranquilizer
use (Brewer, Fleming, Haggerty, & Catalano, 1998; El-
Bassel et al., 2004). Among a probability sample of 3,003
women, Kilpatrick, Acierno, Resnick, Saunders, and Best
(1997) found that women’s drug use at a single point in
time increased their odds of experiencing a violent assault
in the subsequent year by a factor of 1.84, after controlling
for background factors. This study also estimated that new
assaults doubled the risk of drug use in the subsequent
year. A recent study with women in methadone treatment
conducted in New York City by the authors of this article
examined whether frequent drug use increased subse-
quent sexual and physical IPV and whether experiencing
IPV increased the likelihood of subsequent frequent drug
use, using data from wave 2 (6 months postbaseline) and
wave 3 (12 months postbaseline; El-Bassel et al., 2005b).
Findings showed that women who reported frequent
crack cocaine use at wave 2 were four times more likely
than women on methadone who did not use crack to
report physical and sexual abuse at wave 3. Women who
used marijuana at wave 2 were twice as likely as their
counterparts to report physical and sexual abuse at wave
3. This study also found that women who reported IPV
at wave 2 were three times more likely to report heroin
use at wave 3 than their counterparts who did not report
physical and sexual IPV (El-Bassel et al., 2005b).
Several factors may explain these temporal relation-
ships between using drugs and experiencing IPV among
women. First, women under the influence of drugs or
alcohol are less likely to identify risky situations or pick
up on cues of impending sexual coercion and less able
to negotiate condom use in such encounters (El-Bassel,
Gilbert, Rajah, et al., 2000). For example, women
who frequently use crack cocaine may have impaired
judgment, making it more difficult for them to discern
when their partner’s words or actions are escalating to a
threatening level (Miller, Gold, & Mahler, 1991; Spunt,
Goldstein, Bellucci, & Miller, 1990). Second, several
studies have also documented the perilous and degrading
circumstances under which women who exchange sex for
money or drugs operate where coercive sex is common
and condom use infrequent (Edlin et al., 1994; El-Bassel
et al., 1996; Fullilove, Lown, & Fullilove, 1992; Irwin et
al., 1995; Lown, Winkler, Fullilove, & Fullilove, 1993).
In our qualitative study, women indicated that if their
intimate partners provided them with drugs their partners
would often expect sex in return (El-Bassel, Gilbert,
Rajah, et al., 2000). Finally, emerging qualitative research
suggests that drug use among abused women often occurs
as a self-medication response to ameliorate the emotional
and physical pain of experiencing IPV (Gilbert et al.,
2001; Sterk, 1999).
The Low Social Status of Drug-Involved Women
The low social status of women who use crack co-
caine may give their partners greater entitlement to abuse
such women (Gilbert, El-Bassel, Rajah, et al., 2000;
Gilbert et al., 2001; Sterk, Dolan, & Hatch, 1999). Ver-
bal abuse, which is often aimed at the perceived low so-
cial status, sexual promiscuity, and the stigma of being
a drug-dependent woman, may further disempower drug-
involved women from negotiating safer sex. (Gilbert, El-
Bassel, Rajah, et al., 2000; Gilbert et al., 2001; Sterk,
1999). Drug-dependent women are often considered “sex-
ually promiscuous” or “damaged goods”; they are per-
ceived as violating traditional gender role norms and,
thus, more deserving of abuse (Miller, Downs, & Testa,
1993). Experiencing IPV and then taking sexual risks may
thus occur as an extension of the unequal distribution
of sexual, social, and economic power among women,
low social status of drug-involved women, and gender
inequality between men and women within the drug-
using subculture. At the same time, IPV may also occur
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as an extension of a violent subculture associated with
crack in economically disadvantaged urban communities
(Inciardi, Pottieger, Forney, Chitwood, & McBride, 1991;
Johnson, Williams, Sanabria, & Dei, 1989).
Male Partner’s Substance Use as a Mediator of IPV
and HIV Risk
Substance use among male partners may further mediate
the relationship between IPV and HIV risks. In our study
among 356 men on methadone, conducted in New York
City, we found that illicit drug use by both male and fe-
male partners was significantly associated with perpetra-
tion of severe sexual and physical IPV (El-Bassel et al.,
2007). Drug and alcohol use by perpetrators tends to in-
tensify feelings of paranoia, jealousy, and irritability as
well as impair judgments; these psychopharmacological
effects may increase the likelihood of IPV and decrease
the ability to use condoms (Gilbert et al., 2001; Straus
& Gelles, 1990). In qualitative research with women on
methadone, several women described how their partners
became easily irritated when experiencing withdrawal
from drugs, and this irritation increased their risk of sex-
ual IPV that was often followed by physical IPV (El-
Bassel, Gilbert, Schilling, et al., 2000). A number of
women said that their partners insisted on having sex af-
ter physical violence, which they viewed as a way of
restoring their control over the relationship and a return
to status quo (El-Bassel, Gilbert, Rajah, et al., 2000).
Qualitative research further suggests that substance use
by the woman or her partner tends to increase her part-
ner’s expectations for unwanted and unprotected sex (El-
Bassel, Gilbert, Schilling, et al., 2000; Sterk, 1999). A
woman’s refusal to have sex under these heightened ex-
pectations may trigger a violent response from her part-
ner, especially if he is under the influence of alcohol or
drugs.
Both victims and perpetrators tend to believe that per-
petrators under the influence of drugs or alcohol may
not be held accountable for sexual coercion. Qualita-
tive research suggests that women often attributed their
experiences of forced sex to drugs rather than to their
partner’s behavior (El-Bassel, Gilbert, Schilling, et al.,
2000). Such attributions may ironically permit men un-
der the influence of drugs greater power and control
in sexual situations. As long as drugs are blamed for
men forcing sex upon their partners, the men are not
held accountable for their own actions. Such social ex-
pectations may enable partners to continue perpetrat-
ing sexual IPV (Gilbert et al., 2001; Straus & Gelles,
1990).
Couple’s Substance Use and Discrepancies
of Sexual Desire
Discrepancies in sexual desire while both male and
female partners are under the influence of drugs or
alcohol may also create conflict that results in sexual
coercion. In our in-depth interviews with 38 women,
some women attributed the increased likelihood of sexual
IPV to disparities in sexual desire under the influence of
drugs (El-Bassel, Gilbert, & Rajah, 2003). While women
often felt a diminished desire for sex, particularly under
the influence of crack, they reported that their partner
often expressed an increased sexual desire after using
crack and/or heroin but a decreased ability to perform
(El-Bassel, Gilbert, & Rajah, 2003). Findings from these
in-depth interviews suggest that a male partner under the
influence of drugs would continue to insist on sex despite
difficulties with sustaining an erection or ejaculating.
Several women also reported that theyweremore likely
to endure forced sex while they were under the influence
of drugs. Several women also described being forced to
sell sex to procure drugs for their partners. After the fact,
the same partner would physically hurt her for selling sex,
and then, to make up while still under the influence of
the drugs that she purchased, he would force her to have
sex with him to restore his power in the relationship (El-
Bassel et al., 2003).
CHILDHOOD SEXUAL ABUSE AND
POST-TRAUMATIC STRESS DISORDER AS
MEDIATORS OF IPV AND HIV RISK
The relationship between experiencing IPV and engag-
ing in risky sexual behavior may be further mediated
by childhood sexual abuse (CSA) and post-traumatic
stress disorder (PTSD), which have been found to be
associated with IPV (Dansky, Byrne, & Brady, 1999;
Schiff, El-Bassel, Engstrom, & Gilbert, 2002; Wathen
& MacMillan, 2003) and HIV risk behaviors (Hutton et
al., 2001; Lewis, 2005). Previous research indicates that
between 56% and 84% of women in drug treatment pro-
grams have experienced CSA (Cohen & Densen-Gerber,
1982; Freeman, Collier, & Parillo, 2002; Gil-Rivas,
Fiorentine, Anglin, & Taylor, 1997; Medrano, Desmond,
Zule, & Hatch, 1999; Paone, Chavkin, Willets, Friedman,
& Des Jarlais, 1992; Teets, 1995). This range of preva-
lence rates is two to three times higher than the range of
prevalence rates (6%–45%) found in community-based
samples of women (Geffner, 1992; Hashima & Finkelhor,
1999; Morrow& Smith, 1995;Wyatt & Newcomb, 1990).
Results from numerous cross-sectional studies suggest
that CSA is the event that most often leads to PTSD
among women, particularly among drug-involved women
(Breslau, Davis, Andreski, & Peterson, 1991; Kessler,
Sonnega, Bromet, Hughes, & Nelson, 1995; Resnick,
Kilpatrick, Dansky, Saunders, & Best, 1993; Winfield,
George, Swartz, & Blazer, 1990). An accumulation of
data indicates that PTSD is a salient, if not core, compo-
nent of a complex of symptoms related to CSA (Astin,
Ogland-Hand, Coleman, & Foy, 1995; Freeman, Parillo,
Collier, & Rusek, 2001; Gil-Rivas et al., 1997). Further-
more, previous research has found relationships between
PTSD symptoms of disassociation and hyperarousal and
engaging in sexual HIV risk behaviors among women
(Hutton et al., 2001; Lewis, 2005). Thus, there exist
pernicious, cyclical relationships among the co-occurring
problems of PTSD, IPV, substance abuse, and HIV risk.
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CHALLENGES DRUG TREATMENT PROGRAMS FACE
IN DEALING WITH IPV AND ITS RELATIONSHIP
TO HIV
A growing body of evidence suggests that interpersonal
stress and relationship conflicts including IPV among
women in drug user treatment programs are major
triggers for relapse (Leshner, 1998; McKay, Rutherford,
Cacciola, Kabasakalian-McKay, & Alterman, 1996),
continued drug use, and attrition from substance user
treatment programs (Gilbert et al., 2001; Gil-Rivas et al.,
1997; Melchior, Huba, Brown, & Slaughter, 1999). Risks
of IPV may heighten upon a woman’s entry into drug user
treatment because her partner may perceive her attempts
to “get clean” as a sign of abandonment. He may retaliate
with sexual and physical IPV or extradyadic sex, in-
creasing her risks for HIV and other STIs (Amaro, 1995;
Gilbert, El-Bassel, Schilling, et al., 2000). Moreover, abu-
sive partners will often attempt to limit a woman’s access
to drug user treatment or services and social support with
threats or controlling behaviors and dependencies (Gilbert
et al., 2001; Gilbert, El-Bassel, Schilling, et al., 2000).
Although substance user treatment programs have
played a significant role in reducing the spread of HIV
among drug-involvedwomen, and some progress has been
made to include an assessment for IPV, especially at pro-
gram entry, IPV is not always addressed in substance user
treatment programs, and referrals to deal with IPV prob-
lems may not occur. This may be explained by high coun-
selor caseloads, a lack of training of program staff to as-
sess for IPV, few resources, and a scarcity of treatment
approaches in substance abuse programs to deal with IPV
(Kunins, Gilbert,Whyte,Meissner, & Zachary, 2007). Re-
ferrals may not occur because the number of IPV treat-
ment programs or battered women’s shelters that will ac-
cept drug-involvedwomen is low.Many batteredwomen’s
shelters reject drug-involved women completely. In the
past several years, there has been some shift and increase
in the level of awareness of IPV among health practition-
ers and counselors in substance user treatment programs;
however, more needs to be done to address this serious is-
sue. Standard protocols for assessment, safety planning,
and referrals to address IPV among individuals in drug
user treatment programs need to be available to all fe-
male clients. If a woman is currently involved with an abu-
sive partner, counseling staff should be at least minimally
trained to develop a safety plan with her and provide re-
ferrals for ongoing treatment for problems related to IPV.
IMPLICATIONS FOR HIV PREVENTION THAT
ADDRESS THE CO-OCCURRING PROBLEMS
To date, there is a paucity of empirically tested HIV pre-
vention interventions designed for women to specifically
address the problem of concurring HIV risks, IPV, and
substance use. A growing number of researchers, along
with a policy report from the World Health Organization
(1997), have emphasized the need for HIV prevention in-
terventions to incorporate IPV prevention, particularly for
drug-involved women (Belenko, Lin, O’Connor, Sung, &
Lynch, 2005; El-Bassel et al., 2005a; Gilbert, El-Bassel,
Schilling, et al., 2000; Kalichman et al., 1998; Maman
et al., 2000; Raj et al., 2004; Wingood & DiClemente,
1997;Wu et al., 2003). The disproportionately high preva-
lence rates of IPV among drug-involved women under-
score the need to develop HIV prevention intervention
models that synergistically address the multiple contexts
that drive the co-occurring problems of HIV, IPV, and sub-
stance abuse. Integrated HIV prevention intervention ap-
proaches should take into consideration the different con-
texts that increase HIV risks presented in this article, such
as sexual coercion, fear of violence, negotiating condom
use, disclosure of HIV and other STIs to partners, attitudes
toward drug-involved women and gender role power im-
balances, the drug use of women and their male partners,
PTSD and trauma, and relationship dependencies.
Such integrated HIV risk reduction intervention
strategies may include the following cognitive behavioral
components: (1) raising awareness of the interpersonal
contexts and triggers of HIV risk behavior and IPV, for
example, considering how requests for condom use in an
intimate relationship may trigger sexual and physical vio-
lence and how fear and experience of IPV prevents some
drug-involved women from protecting themselves from
HIV; (2) developing an accurate appraisal of risk of HIV
and IPV as well as increasing safety planning, problem
solving, and sexual communication skills to negotiate
safer relationships with their partners; and (3) increasing
access and utilization of services and bolstering informal
social support to help women establish and maintain
relationship safety. It is very important that the integrated
HIV prevention intervention approaches take into account
the balance of power in intimate relationships, level of
sexual communication and negotiation skills, relationship
dependencies, and history of trauma and PTSD.
Failure to address the co-occurring problems of HIV
risk and IPV in an integrated approach for women in
drug user treatment may not only increase their risk of
HIV but also jeopardize their recovery and safety. More-
over, in order to change social norms toward violence
against women, HIV prevention efforts should also tar-
get all women andmen attending substance user treatment
programs and raise their awareness of the scope of vio-
lence against women and the resources available for IPV.
Informational prevention strategies can be disseminated
through workshops, the distribution of brochures, and me-
dia such as informative videos shown in waiting rooms
of clinics. Such dissemination of information in conjunc-
tion with an integrated behavioral intervention can focus
on building a continuum of relationship safety strategies
that synergistically focus on both IPV and HIV prevention
among drug-involved women.
In sum, HIV continues to be a serious epidemic among
drug-involved women in New York City, disproportion-
ately affecting African American and Latina women, the
majority of whom are infected through heterosexual con-
tact (New York City Department of Health and Men-
tal Hygiene, 2007). Despite a quarter of a century of
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accumulated research demonstrating that behavioral pre-
vention interventions can curb HIV risks among adult
women, few US evidenced-based HIV intervention mod-
els have focused exclusively on drug-involved women. In
order to reduce the HIV epidemic among women in drug
user treatment programs in New York City, special atten-
tion needs to be paid to the design, testing, and imple-
mentation of women-specific HIV prevention approaches
that address the co-occurring mechanisms and mediators
related to HIV and drug abuse described in this article.
Our research on HIV and IPV among women in drug user
treatment programs in New York City has elucidated a
number of mechanisms that link HIV and IPV (sexual co-
ercion, fear of violence, disclosure of HIV and STIs, re-
lationship dependencies, and drug use of the perpetrators
and the victims) and mediators (CSA and PTSD).
Addressing the mechanism and mediators of IPV in
HIV prevention is critically needed because IPV plays a
significant role in escalating heterosexual transmission of
HIV. Condoms are less likely to be used by partners in
a long-term relationship where IPV is present. Although
drug user treatment programs in New York City have
made some progress in recognizing that IPV is a risk for
HIV, and a few programs include an assessment for IPV
in their intake protocols, the use of evidenced-based in-
terventions in the co-occurring problems of HIV and IPV
have rarely been implemented. This is because of the lack
of available evidenced-basedmodels that incorporate both
IPV and HIV, and as a result, less attention is paid to
these co-occurring problems among women. Addressing
this shortcoming would have important public health im-
plications for HIV prevention for drug-involved women in
New York City.
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